Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 934

Ribometrix rips $30m in Merck-led round

Merck Group's M Ventures unit led the RNA therapy startup's series A round, which featured Amgen, Illumina, AbbVie and Mitsubishi Tanabe Pharma.

Nov 16, 2018

Velox inks $32m funding round

Altana and existing investor Evonik both contributed to a round for the printing technology developer that was co-led by ORT Technologies.

Nov 16, 2018

Axoni racks up $36m in series B

HSBC added $4m to a series B round for blockchain financial product developer Axoni that includes NEX Group, Citi and Wells Fargo.

Nov 16, 2018

SAM Seamless fixes $12m series A round

Intel Capital led a round for the network cybersecurity platform developer that included ADT, with the cash to go to international growth and research and development.

Nov 15, 2018

You.i TV channels $23m from investors including WarnerMedia

Returning investor WarnerMedia has reinvested in the video engagement platform developer's latest round, which was led by Causeway Media Partners.

Nov 15, 2018

ClearSky stores $20m in new funding

The Akamai-backed data recovery and storage platform developer took its overall funding to almost $60m in a round that included an undisclosed corporate investor.

Nov 15, 2018

Mobeewave mobilises Mastercard for series B round

The mobile payment technology developer has closed a $16.5m round co-led by Mastercard, three years after an Sberbank-funded series A.

Nov 15, 2018

EdX enrols in Unicaf's $28m series B

Online higher education platform Unicaf has raised series B funding from a consortium including Goldman Sachs, EdX and CDC Group as it gears up to target more students.

Nov 15, 2018

Instacart increases series F funding to $871m

Amex, Comcast and Amazon-backed grocery delivery platform Instacart has added $271m to its latest round and is now valued at almost $7.9bn.

Nov 15, 2018

Kleo collects $21m in series B round

PeptiDream has led immuno-oncology drug developer Kleo Pharmaceuticals’ series B round, which also featured existing investor Biohaven.

Nov 15, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here